Abstract
Background
Early, sensitive and reproducible evaluation of left ventricular (LV) function is imperative for diagnosis of cardiac dysfunction in Duchene muscular dystrophy (DMD) patients. We hypothesized that combining 2D-strain analysis with catecholamine stress could be a sensitive method for detecting early cardiac dysfunction.
Methods
mdx (C57BL/10ScSn-Dmdmdx/J, a mouse model of DMD) and control (C57BL/10ScSn) mice were studied with conventional M-mode and high frequency ultrasound based 2D speckle tracking echocardiography (STE)using long- and short-axis images of LV at baseline and after isoprenaline (2μg/g BW, i.p.).
Results
Conventional M-mode analysis showed no differences in LV fractional shortening, wall thickness or internal diameter at diastole between mdx and control mice before the age of 6 months. Isoprenaline increased LV ejection fraction and fractional shortening to the same extent in mdx and control mice at young ages (3, 4 and 5 months). No differences in basal peak systolic strain (PSS) but increased standard deviations of times to PSS between young mdx and control mice were found. After isoprenaline, PSS and percentile changes of PSS were significantly diminished in mdx mice compared to control mice at young ages. Isoprenaline increased normalized maximum difference of times to PSS in young mdx mice but not in young control mice, suggesting isoprenaline reduces cardiac contractile synchrony in young mdx mice.
Conclusions
Our study suggests that catecholamine stress coupled with 2D strain analysis is a feasible and sensitive approach for detecting early onset of cardiac dysfunction, which is instrumental for early diagnosis of cardiac dysfunction and early treatment.
Keywords: Duchenne muscular dystrophy cardiomyopathy, Myocardial reserve, Stress echocardiography, Strain, mdx mouse
Introduction
Duchenne muscular dystrophy (DMD) is a hereditary X-linked recessive disease resulting from the mutation of the dystrophin gene[1], which affects 1 in 3500 male births. An early manifestation of DMD is weakness in the skeletal muscle [2]. A weakened diaphragm may cause death of DMD patients at young ages due to respiratory failure, but with the support of mechanical ventilators, DMD patients can now survive much longer than they did a decade ago [2]. Cardiomyopathy is becoming a more important cause of mortality and morbidity in DMD patients [3]. At rest, cardiac dysfunction can be detected during the early teenage years in DMD patients. With more advanced technologies, such as three dimensional (3-D) strain, distortion and dispersion analyses, cardiac dysfunction at rest can be detected as early as the age of 8 or 9 years [4, 5]. Reduced cardiac reserve is an early indication of cardiac dysfunction and is evaluated with a treadmill test or dobutamine test in the clinic. However, there were few reports regarding cardiac reserve in DMD patients.
Mouse models, such as x-linked muscular dystrophy (mdx) mice, have been used to investigate the pathophysiology of and to test new therapies for DMD [6, 7]. To develop a safe and effective therapy for cardiomyopathy in DMD, early, sensitive and reproducible measurements of left ventricular (LV) remodeling and dysfunction are needed. High frequency ultrasound has become a valuable tool to phenotype cardiac structure, hemodynamics, and global function in small animals [8–10]. Furthermore, high frequency ultrasound based 2D speckle tracking echocardiography (STE) has been used to quantitatively measure myocardial strains and strain rates as potentially sensitive markers for early regional myocardial dysfunction in mdx mice, showing that peak systolic strain (PSS) analysis is feasible and reproducible for detecting LV dysfunction in mdx mice [11].
The catecholamine (e.g., dobutamine in the clinic or isoprenaline in animal experiments) stress test has been used to evaluate cardiac reserve in many studies [12–14]. Previously, using invasive in vivo intra-left ventricular hemodynamic measurement and ex vivo Langendorff system, we found that cardiac β-adrenergic response was reduced in 4-month old but not in 2-month old mdx mice. In a sixteen-year old DMD patient, it was found that there was reduced cardiac response to dobutamine stress although his left ventricular systolic function was normal at rest [15]. However, the use of the combination of the catecholamine stress test and high frequency ultrasound-based 2D STE to detect early cardiac dysfunction in DMD patients or animal models has not been reported. Therefore, we hypothesize that reduced abnormal β-adrenergic response of mdx at young ages could be detected by the combination of catecholamine stress with LV strain analysis but not by conventional echocardiography or 2D STE at rest alone.
Methods
Animal models
All mice were handled in compliance with the “Principles of Laboratory Animal Care” by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” published by the National Institutes of Health (NIH publication 85-23, revised 1996). The research protocol was approved by the Institutional Animal Care Committee of the Temple University. Mdx (C57BL/10ScSn-Dmdmdx/J) and control mice (C57BL/10ScSn) (The Jackson Laboratory, ME) were used at the ages as indicated in the figures for studying cardiac morphology and function at rest. Both male and female animals were used. Three sets of animals were used for the study. We used the first set of animals (control: n=10; mdx: n=8) to detect cardiac function alterations for a year with conventional echocardiography. The 2nd set of animals (7control and 7 mdx mice) were used for detecting the changes of cardiac strains at the ages of 6m, 9m and 12m with high frequency ultrasound 2D imaging followed by 2D STE analysis. The 3rd set of mice included a total of 21 mdx and 21 control mice; separate sets of 7 mdx and 7 control mice each were studied at three separate time points (3mos, 4mos, and 5mos) for combined high frequency ultrasound analysis and isoprenaline stress to avoid potential carryover effect of previous isoprenaline injection. Since the mdx mouse model is a model with mild disease progression [16], none of the mice died during the one-year study period.
Echocardiography
A high frequency ultrasound system (Vevo 770, VisualSonics, Toronto, Ontario) was used for acquiring ultrasound images. A single-crystal mechanical transducer (RMV 707B) with a central frequency of 30 MHz (15–45MHz) and focal length of 12.7 mm was used. The Vevo 770 machine with RMV 707B scanhead has a lateral resolution of 115μm, an axial resolution of 55μm and up to 240 frames per second, allowing us to acquire high resolution images for conventional echocardiography and speckle tracking analysis when combined with a proprietary software [17], Tomtec Image Arena 4.0.
Mice were anesthetized using 3% isoflurane initially and then maintained at 1.5%. The animals were laid in a supine position on a heated platform with all legs taped to ECG electrodes for ECG recording. Body temperature was monitored via a rectal thermometer and maintained at 36–38°C. Hair was removed from the chest using chemical hair remover prior to imaging.
M-mode and 2D high frequency ultrasound
Eight mdx and ten control mice were followed for conventional M-mode analysis every two months until the age of 12 months to evaluate cardiac morphology and function. M-mode images were obtained using LV short-axis view at the mid papillary muscle level. M-mode gate was set in the middle between the two papillary muscles for ejection fraction and fractional shortening analysis.
For 2D STE studies, short-axis B mode cine loops were obtained at the mid LV level as described above and long-axis B mode cine loops were recorded with scanhead placed at the mid-LV level, i.e., along the left sternal border with clear view of both the apex and the outflow tract of LV [18]. At the ages of 3m, 4m, and 5m, 7 mdx and 7 control at each age were studied without reuse because they were also used for isoprenaline stress. For ages of 6m, 9m, and 12m, 7 mdx and 7 control mice were followed serially. The field of view was adjusted to maximize the display resolution of the region-of-interest (ROI) and the frame rates (up to 160fps for short-axis images and 120fps for long-axis images). Image gain and other parameters were adjusted carefully to delineate all myocardial segments. All images were acquired for multiple cardiac cycles and stored digitally in the hard drive for offline analysis.
LV ventricular remodeling and global functional measurements, including LV end-diastolic dimension (LVEDD), LV end-systolic dimension (LVESD), EF and FS were derived from M-mode using high frequency ultrasound by averaging 3 consecutive and stable cardiac cycles.
High frequency ultrasound with isoprenaline stress
High frequency ultrasound with isoprenaline stress was performed for mdx and control mice at the ages of 3, 4, and 5 months. At each age, 7 control and 7 mdx mice were used. Mice were not reused after isoprenaline stress to avoid potential complications. After long- and short-axis M-mode images and B-mode cine loops of LV were acquired at baseline, isoprenaline was injected intraperitoneally (2μg/g BW) [19]. The animals were fully anesthetized to avoid pain response during ISO injection, and had the heart rates between 400–450bpm. The relatively low heart rate also allowed us to get more images for each cardiac cycle and thus better strain analysis. Images were acquired every minute for up to 14 minutes after isoprenaline injection. Long-axis cine loops and M-mode images of the LV were acquired at 1min, 3min, 5min, 7min, 9min, 11min and 13min after injection. Short-axis cine loops and conventional M-mode images of the LV were acquired at 2min, 4min, 6min, 8min, 10min, 12min and 14min after injection. The images and cine loops showing maximum responses to isoprenaline were used for stress response analysis.
Offline strain analysis
Since cardiac muscle degeneration and cardiac dysfunction are heterogeneous in different regions of the heart in DMD patients [20] and there has been thus far no report about epicardial and endocardial strains in mdx mice, we analyzed endocardial and epicardial strains of different regions of the heart including 6 segments of short-axis cine loops and 6 segments of long-axis cine loops. B-mode cine loops of short-axis and long-axis recorded with a 707B scanhead (15–45MHz, 100–240 frames per second) of a Vevo 770 System (FUJIFILM Visual Sonics, Inc., Toronto, Canada) were converted to DICOM format without compression and imported into Tomtec Image Arena 4.0 (Tomtec, Munich, Germany) for offline strain analysis. Tomtec Image Arena has been widely used as a vendor-independent cardiac strain and time to peak analysis. All analyses were based on at least three successive and stable cardiac cycles. Longitudinal, circumferential and radial global peak systolic strains (PSS) of the left-ventricular (LV) endocardium and epicardium were obtained by manual tracing, editing and semi-automated tracking of LV myocardial deformation. The software automatically divides the long-axis LV images into 6 segments: basal anterior (bAnt), mid anterior (mAnt), apical anterior (aAnt), apical posterior (aPst), mid posterior (mPst) and basal posterior (bPst) (Supplemental Figure 1A). The software also divides the short-axis images into 6 segments: anterior (A), anterior septum (AS), posterior septum (PS), inferior (I), posterior (P) and lateral (L) (Supplemental Figure 1B). Strain measurements in each segment were averaged and the peak systolic strains of all segments were further averaged to obtain the peak systolic strain (PSS). Five PSS measurements were determined: longitudinal PSS of the endocardium (L-Endo), longitudinal PSS of the epicardium (L-Epi), circumferential PSS of the endocardium (C-Endo), circumferential PSS of the epicardium (C-Epi), radial PSS (R) (Supplemental Figure 2 and 3). L-Endo and L-Epi PSS were analyzed with long-axis cine loops and C-Endo, C-Epi and R PSS were obtained from short-axis cine loops obtained at the mid-LV level. EF, FS and PSS measurements were made under baseline and isoprenaline stress conditions. Maximum values for EF, FS and PSS after ISO injection were selected for statistics. Percentage increase of PSS measurements were calculated as: (difference between the measurements after and before isoprenaline injection/measurement before isoprenaline injection) × 100 %. To determine dyssynchrony of left ventricle segments, the maximum time difference between times to peak systolic strain of segments (maximum ΔTpeak) was determined. The standard deviation of times to peaks of six segments of each heart were normalized to the cardiac cycle (i.e., RR interval) to further characterize the dyssynchrony of contractions. The person performing the echo analysis was blinded to the mice population.
Intra-observer and Inter-observer Variability
A total of 20 data sets at rest and 20 data sets during stress were selected, and measurements were made by two blinded, experienced observers to determine intra- and inter-observer variability. To determine the intra-observer variability, one observer analyzed and measured the strain data (PSS) from rest and stress echocardiography results twice at a 4-week interval, while blinded to the results of the first measurements. A second observer, blinded to the results of the first observer, also analyzed and measured the strain data independently to determine the inter-observer variability. The intra- and inter-observer variabilities were expressed as percentile differences: (absolute difference between the measurements/mean of the measurements) × 100 %.
Statistical Analysis
Continuous variables were presented as mean ± standard error of the mean (SEM). The difference between 2 continuous variables was tested using a t-test with a 2-tailed distribution or one-way or two-way ANOVA with or without repeated measurements. Bonferroni adjustment was done for comparison between pairs for ANOVA analyses. Statistical significance was defined as P<0.05. All statistical analyses were done using SPSS statistical software package (version 17.0; SPSS Inc, Chicago, IL).
Results
Conventional M-mode high frequency ultrasound analysis in combination with isoprenaline stress test cannot detect cardiac dysfunction in young mdx mice
We first used conventional M-mode analysis to determine cardiac function in mdx and control mice every two months from the age of two months until the age of 12 months (Figure 1). This technique only detected reduced cardiac dysfunction in mdx mice at rest after the age of 8 months (Figure 1B) while diastolic LV posterior and septal wall thickness increased (Figure 1C and D). The diastolic LV internal diameter decreased slightly due to the increases in LV wall thickness in mdx mice seen at the age of 8 months (Figure 1). These results agree with those from previous studies [14, 21].
Figure 1.
Cardiac morphology and function evaluation by conventional M-mode echocardiography in control and mdx mice at the ages of 2, 4, 6, 8, 10 and 12 months. When the animals were imaged, the heart rate was kept in the range of 400–450 beats per minute (bpm) and there was no difference in heart rates between groups (A). Fractional shortening (B), diastolic left ventricular posterior wall (LVPD;d) thickness (C), diastolic interventricular septum (IVS;d) thickness (D), diastolic left ventricular internal diameter (LVID;d) (E) and corrected LV mass (F) were compared between control and mdx mice at different ages. ** or *: p<0.01 or p<0.05 mdx vs. control at the same age; ## or #: p<0.01 or p<0.05 vs. 2m-old mdx mice. $$ or $: p<0.01 or p<0.05 vs. 2m-old control mice. The black numbers are the numbers of control mice studied and the gray numbers are the numbers of mdx mice studied.
Since altered β-adrenergic reserve is an early indication of cardiac dysfunction [22], we tested if young mdx mice (ages 3, 4, and 5 months) had reduced cardiac reserve with a catecholamine (isoprenaline, 2μg/g BW, i.p.) stress test assessed by conventional M-mode echocardiography. During stress, LVEF and LVFS increased gradually after injection and reached peak value within 3–7mins (4.25±1.16mins) for all mdx and control mice. ISO significantly increased heart rate (HR), LVEF and LVFS in both control and mdx mice at the ages of 3, 4 and 5 months. After ISO, there was no difference in HR, EF and FS between control and mdx mice of the same age (Figure 2).
Figure 2.
Effects of isoprenaline (ISO) on cardiac function evaluated by conventional echocardiography. A & B. M-mode images of control (A) and mdx (B) mice at baseline and after ISO. C. Heart rates of control (3-, 4- or 5- month old, 5 mice per age group) and mdx mice (3-, 4- or 5- month old, 7 mice per age group) before and after ISO. D. Left ventricular fractional shortening of control and mdx hearts before and after ISO. ** or *: p<0.01 or p<0.05 ISO vs. rest at the same age of control mice; ## or #560: p<0.01 or p<0.05 ISO vs. rest at the same age of mdx mice.
High frequency ultrasound speckle tracking echocardiography (STE) does not detect cardiac dysfunction in young mdx mice at baseline
It has been reported that cardiac strain analysis is a more sensitive method for detecting local and global cardiac dysfunction [23]. We used this method to determine if it could reveal a difference between young mdx and control mice. At the ages of 3 and 4 months, there was no difference in PSS between mdx and control mice. PSS started to decrease in mdx mice at the age of 5 months, and the differences in L-endo PSS and Radial PSS reached statistical significance at the age of 6 months, progressing with age. Differences in L-epi and C-endo PSS between mdx and control mice were significant at the ages of 9 months and 12 months (Figure 3). The impairment of strain in mdx mice appeared earlier and more severe in the endocardium than in the epicardium, indicating endocardial PSS were more sensitive measurements of regional cardiac dysfunction in mdx mice. These data show that strain analysis is only able to detect cardiac contraction differences between control and mdx mice after the age of 6 months.
Figure 3.
Peak systolic strain (PSS) of control and mdx mice at the ages of 3, 4, 5, 6, 9 and 12 months. Longitudinal endomyocardial (L-endo) PSS (A), longitudinal epimyocardial (L-epi) PSS (B), circumferential endomyocardial (C-endo) PSS (C), circumferential epimyocardial (C-epi) PSS (D), and radial PSS (E) were measured at rest. *: p<0.05 mdx vs. control mice at the same age.
Peak systolic strains in young mdx mice had reduced response to isoprenaline
During stress, LVEF, LVFS and PSS increased gradually after injection and all reached peak value between 3–7mins (4.25±1.16mins) for all mdx and control mice. Endocardial and epicardial PSS in longitudinal, circumferential and radial directions increased significantly in control and mdx mice with isoprenaline stimulation (Figure 4). In control mice of 3–5months, age did not significantly change PSS at baseline or after isoprenaline. Isoprenaline also significantly increased PSS in young mdx mice, but the increases in most PSS were less in mdx mice than in control mice except in L-Epi and C-Epi PSS at the age of 3 months. From the age of 3 months to 5 months, PSS responses to isoprenaline in mdx mice tended to decrease with age. For L-Endo and R PSS during stress, significant differences between mdx and control mice appeared in all age groups from 3 to 5 months (Figure 4). However, for L-epi and C-endo PSS, the differences between mdx and control mice after isoprenaline were not significant at the age of 3 months but reached significance at the age of 5 months. For C-Epi PSS, differences between mdx and control mice could not be detected in the 3, 4, and 5 month groups.
Figure 4.
Peak systolic strain (PSS) of young control and mdx mice at the ages of 3, 4, and 5 months before and after maximum isoprenaline effect. Animals were anesthetized with isoflurane to keep the heart rate within the 400–450 beats per minute (bpm) range. Baseline short-axis and long-axis B-mode images were recorded at rest and then isoprenaline (ISO, 2μg/g BW) was injected intraperitoneally. Short-axis and long-axis B-mode images were recorded every minute until 15 minutes after ISO injection. Maximum PSS values after ISO were used to reflect maximum effect of ISO. Longitudinal endomyocardial (L-endo) PSS (A), longitudinal epimyocardial (L-epi) PSS, circumferential endomyocardial (C-endo) PSS (C), circumferential epimyocardial (C-epi) PSS (D), and radial PSS (E) were measured before and after ISO. *, **, ***: p<0.05, p<0.01, p<0.001 ISO vs. baseline in control mice at the same age; #: p<0.05, ISO vs. baseline in mdx mice at the same age; $574, $$, $$$575: p<0.05, p<0.01, p<0.001 control vs. mdx after ISO at the same age. Two-way repeated ANOVA with post-hoc tests with Bonferroni adjustment was done for comparing pairs.
Percentage increases of LV PSS were less in young mdx mice as compared to young control mice
Since there were subtle differences in baseline PSS between mdx and control mice, we determined the percentage increase of LV PSS to better compare the effects of isoprenaline on (Figure 5). There were significantly lower percentage increases of L-Endo, C-Endo and R PSS in mdx mice than in control mice of 3, 4, and 5 months (Figure 5A, C and E). The percentage increases of L-Epi PSS and C-Epi PSS were not significantly different between mdx and control mice at the ages of 3 and 4 months. At the age of 5 months, the increases of these two PSS reached statistical significance between mdx and control mice (Figure 5B and D). These data suggest that the combination of 2D strain analysis and isoprenaline stress can detect reduced cardiac functional reserve in mdx mice starting at a very young age (3 months). L-endo PSS, C-endo PSS and R PSS were more sensitive than L-epi PSS and C-epi PSS for distinguishing between control and mdx mice.
Figure 5.
Percentage of increase in each PSS by isoprenaline (ISO, 2μg/g BW, i.p.) in control and mdx mice at the ages of 3, 4 and 5 months. The percentage of increase of L-endo (A), L-epi (B), C-endo (C), C-epi (D) and radial (E) PSS by ISO was compared between young mdx and control mice. *, **, ***: p<0.05, p<0.01, and p<0.001 mdx vs. control at the same age; statistical analysis was done using one-way ANOVA with post-hoc test with Bonferroni adjustment.
β-adrenergic stimulation decreases myocardial contraction synchrony in young mdx mice
To determine if there is dysynchrony of myocardial contractions at baseline or after β-adrenergic stimulation in young mdx mice, standard deviations and maximum differences of times to peak of strains (ΔTpeak,max) were analyzed for epicardium and endocardium in the longitudinal, circumferential and radial directions. At baseline, no difference in ΔTpeak,max in all directions was observed between 3-, 4-, and 5-month old control and mdx mice. ISO stimulation did not significantly alter ΔTpeak,max in control mice of all three age groups or in 3-month mdx mice. However, ISO significantly increased L-endo and C-endo ΔTpeak,max in 5-month old mdx mice, suggesting that ISO increases dyssynchrony in 5-month old mdx mice (Supplemental Figure 5). Since ISO increased the heart rate and reduced cardiac cycle duration, we normalized ΔTpeak,max to cardiac cycle duration. Again, ISO did not significantly change ΔTpeak,max/CC in control mice but significantly increased L-endo, C-endo and radial ΔTpeak,max/CC in 4-month mdx mice and ΔTpeak,max/CC in all directions (L-endo, L-epi, C-endo, C-epi and radial) in 5-month old mdx mice (Figure 6). It seems that the normalization of ΔTpeak,max to CC is a more sensitive parameter for evaluating myocardium dyssynchrony, and ISO increases myocardium dyssynchrony in mdx mice. The early contraction or delayed contraction was not restricted to a specific region in the mid-level short axis and long axis videos (Supplemental Tables 1–3).
Figure 6.
Maximum differences in time to peak (ΔTpeak, max) of systolic strains normalized to the duration of cardiac cycle (CC) of young control and mdx mice at the ages of 3, 4, and 5 months before and after maximum isoprenaline effect. ΔTpeak, max was measured when a maximum effect of ISO (2μg/g BW) was observed. ΔTpeak, max/CC ratios of longitudinal endomyocardial (L-endo) (A), longitudinal epimyocardial (L-epi) (B), circumferential endomyocardial (C-endo) (C), circumferential epimyocardial (C-epi) (D), and radial (E) strains were analyzed before and after ISO. #, ##587: p<0.05, p<0.01, ISO vs. baseline in mdx mice at the same age; $, $$588: p<0.05, p<0.01, control vs. mdx after ISO at the same age. Two-way repeated ANOVA with post-hoc tests with Bonferroni adjustment was done to compare pairs.
We also studied the dysynchrony of PSS by analyzing the standard deviation of time to peak (SDTpeak) of PSS. Baseline SDTpeak was not significantly changed in control mice but increased in mdx mice during the growth from 3m to 5m, reaching statistical significance between these two groups of mice at the age of 5 months for all PSS and at the age of 4m for L-endo PSS. ISO decreased SDTpeak in all mice but did not further enhance the difference in SDTpeak between control and mdx mice (Supplemental Figure 6). When SDTpeak was normalized to cardiac cycle (SDTpeak/CC), there were significant differences in the SDTpeak/cc of L-endo and L-epi PSS at the age of 4 months and of all PSS at the age of 5 months between control and mdx mice at baseline or after ISO (Figure 7).
Figure 7.
Standard deviations (SD) of Tpeak of systolic strains normalized to cardiac cycle (CC, i.e., R-R interval) of control and mdx mice at baseline and after maximum isoprenaline effect. SD of Tpeak/CC of L-endo (A), L-epi (B), C-endo (C), C-epi (D) and radial (E) strains. $594: p<0.05, mdx vs. control at baseline at the same ages; &595: p<0.05, p<0.01, control vs. mdx after ISO at the same age. Two-way repeated ANOVA with post-hoc tests with Bonferroni adjustment was done for comparing pairs.
Intra-observer and Inter-Observer Variability in STE measurements
Intra-observer and inter-observer variabilities for specific PSS were less than 10% as shown in Table 1 and the Bland-Altman plots in supplemental Figures 7–8. The intraclass correlation of intra-observer and inter-observer observations were all greater than 0.90.
Table 1.
Intra-observer and inter-observer variation and intraclass correlation of L-Endo, L-Epi, C-Endo, C-Epi, and R PSS at rest and after ISO stress (mean±SD)
| Rest (n=20) | Stress (n=20) | |||||||
|---|---|---|---|---|---|---|---|---|
| Strains | Intra-observer | Inter-observer | Intra-observer | Inter-observer | ||||
| Variation (%) | ICC | Variation (%) | ICC | Variation (%) | ICC | Variation (%) | ICC | |
| L-Endo | 5.30±3.16 | 0.965 | 6.58±4.43 | 0.947 | 5.57±3.95 | 0.958 | 6.79±4.73 | 0.921 |
| L-Epi | 6.09±4.41 | 0.932 | 7.08±3.85 | 0.970 | 6.21±4.62 | 0.927 | 7.52±4.74 | 0.960 |
| C-Endo | 5.74±3.26 | 0.936 | 6.64±3.33 | 0.958 | 6.13±4.12 | 0.931 | 6.91±4.02 | 0.951 |
| C-Epi | 6.82±4.07 | 0.900 | 7.06±3.91 | 0.960 | 7.12±4.62 | 0.920 | 8.16±4.59 | 0.934 |
| R | 5.73±3.84 | 0.929 | 6.54±3.71 | 0.956 | 5.94±3.80 | 0.932 | 7.88±4.68 | 0.917 |
ICC: intraclass correlation.
Discussion
In this study, we evaluated the cardiac function of mdx mice and control mice serially with conventional echocardiography and 2D STE strain analysis both with and without a concurrent catecholamine stress test. We made the following observations that: (1) At baseline, neither conventional echo nor 2D STE strain analysis is sensitive enough to detect cardiac dysfunction of mdx hearts younger than 5 months; however, 2D STE strain analysis combined with a catecholamine stress test clearly showed reduced β-adrenergic responsiveness in 3-month old mdx mice. (2) ISO stimulation revealed that there was regional contraction dyssynchrony within seemingly normal young mdx hearts at baseline. These results suggest that the combination of catecholamine stress and echocardiographic 2D strain analysis can be a sensitive approach to detect reduced cardiac reserve in young mdx mice.
Detection of cardiac dysfunction with conventional echo, 2D-STE in combination with catecholamine stress in mdx mice
Conventional M-mode analysis has been used to evaluate global cardiac functions and morphology such as EF, FS, wall thickness and chamber diameter in mdx mice and DMD patients. It detects cardiac dysfunction during the teenage years in DMD patients [24] and after the age of 6–9 months in mdx mice [25–27]. The echocardiography technology has now advanced from global to local (e.g., motility, torsion, and strain) analysis [8, 23], which has been used in DMD patients [4, 20, 28, 29] and mdx mice [11] to diagnose cardiac dysfunction and is more sensitive than conventional echo in detecting cardiac function abnormalities. In our study, it seems that PSS is more sensitive for detecting the decrease in cardiac function than conventional M-mode.
Using strain analysis to measure cardiac dysfunction in young muscular dystrophy patients has been just considered as feasible and reproducible in 2015 [5] and a clinical trial to prove this has just begun in 2015 and is enrolling patients (ClinicalTrials.gov Identifier: NCT02418338).
The catecholamine stress test has been widely used in clinical diagnoses of patients [30–32] and animal models to detect altered β-adrenergic response [33, 34]. Dobutamine, a β1-adrenergic receptor selective agonist, is often used for patients while isoprenaline, an adrenergic agonist activating both β1- and β2-adrenergic receptors, is often used for animals [30–32]. Combining dobutamine stress with STE has been used in the clinic to determine ischemic region [35] and predict myocardial recovery after revascularization [36]. In this study, we combined isoprenaline stress with echocardiography to determine if β-adrenergic responses of 3–5 month old mdx hearts were altered. Two dimensional-strain analysis in combination with catecholamine stress showed significant decreases in the responses of L-endo and radial PSS to isoprenaline at the age of 3 months. These results suggest that the combination of 2D-STE strain analysis and catecholamine stress is more sensitive than both 2D-STE strain analysis alone and the combination of conventional M-mode and catecholamine stress, which is a novel finding in this study. It seems that at rest and after isoprenaline, endocardial PSS are more sensitive than epicardial PSS to detect cardiac dysfunction in mdx mice. This could reflect the true sensitivity but also could be due to greater variation of epicardial strains. As Tomtec Image Arena 4.0 could not analyze average PSS of the full thickness of the left ventricular wall, it warrants further study to determine if the average PSS of the full thickness of the left ventricular wall could have the same sensitivity as endocardial PSS with other ultrasound imaging systems.
It is evident that different PSS measurements have varying sensitivities in distinguishing mdx and control mice. L-Endo and R PSS are the most sensitive measurements for detecting the difference between control and mdx mice. Endocardial PSS were more sensitive than epicardial PSS to distinguish between mdx and control mice. This may be caused by the structural and functional differences between the endocardium and epicardium. The endocardium contributes more to systolic movement of the heart than the epicardium [37–39]. Therefore, the sub-endocardial strain analysis may provide more information for early diagnosis of abnormal cardiac function/reserve.
When the increase of PSS is expressed as the percentage of increase, it is more sensitive than absolute PSS increase in differentiating mdx mice from control mice. For example, the C-Endo PSS could only detect altered cardiac β-adrenergic response in 5-month old mdx mice, but the percentage of increase in C-Endo PSS could differentiate between mdx mice and control mice of 3, 4, and 5 months. In normal human subjects, the strain responses to dobutamine depends on the age and the dose of dobutamine. Strains of young and healthy hearts have positive responses to low doses of dobutamine but may have plateau or slight decreases at peak doses of Isoprenaline such as 40μg/kg BW when there are significant increase of heart rates and decrease of stroke volume [40]. Even at high dobutamine or isoprenaline doses, the strain rate may still have a positive response [40] and thus could be more sensitive than strain for assessing cardiac β-adrenergic reserve.
Potential mechanisms of loss of β-adrenergic response in young mdx mice
Reduced β-adrenergic reserve is often an early alteration in the diseased heart [41]. The loss of dystrophin in DMD patients and mdx mice makes cardiomyocytes prone to death, causing injury of the heart even in young patients and mdx mice [42]. We detected significant myocyte dropout and replacement fibrosis in 2-month old mdx mouse hearts, but normal baseline cardiac function with ultrasound analysis [14]. The loss of cardiomyocytes in mdx mice may cause reactive β-adrenergic/sympathetic system activation, which has been indicated by the high basal heart rate in mdx mice and DMD patients [43] and high basal PKA activity in mdx mice [14]. Upon persistent activation of the sympathetic/adrenergic system (SAS), the myocytes may develop desensitization, e.g., the decrease of β1-AR adrenergic receptors in ventricular myocytes, as we reported previously [14]. We also showed that young mdx mouse myocytes functionally remodel to enhance myocyte contractility to compensate for the loss of myocytes. This remodeling leaves less room for β-adrenergic agonists to stimulate myocytes [14]. In a single patient case report, it was shown that a 16-year old DMD patient had reduced cardiac contractile reserve upon dobutamine stimulation [15], supporting that dobutamine stress combined with echocardiography as an effective tool to diagnose cardiac dysfunction in DMD patients. In fact, 3-month old mdx mice is considered at very early stage of muscular dystrophy because of the slow progression of the disease in this model [16], but our approach was able to detect significant cardiac dysfunction.
Interestingly, we found no change in HR responses to isoprenaline between mdx and control mice at the ages of 3, 4 and 5 months, suggesting that the alterations of β-adrenergic responses of different cardiac regions, i.e., the sinoatrial node versus ventricular myocardium, could be different. Such dissociation of chronotropic and ionotropic response to β-adrenergic stimulation has been reported in normal aging human heart [44].
The increases in myocardial dyssynchrony in young mdx mice after ISO stimulation
The normal function of the left ventricle relies on synchronous contraction of all portions of the ventricular wall to effectively pump the blood out of the heart [45]. The synchrony of contractions of different myocardial regions can be assessed by maximum difference in times to peak strains (ΔTpeak, max) and standard deviation of Tpeak. Dyssynchronized contraction of different portions of the left ventricular wall is often a subtle alteration of cardiac function before the appearance of overt cardiac dysfunction. In DMD patients, it was reported that posterolateral myocardial strain was delayed [20] corresponding to worse myocardial atrophy and fibrosis in this region. However, in young mdx mice, the fibrosis displays a random and scattered pattern [46] and we found no delay in a specific region (Supplemental Tables 1–3) at rest. Accordingly, we found that at baseline, all portions of the left ventricle in young mdx and control mice contract synchronically with the ΔTpeak, max less than 30 milliseconds at the heart rate of 400–450 beats per minute. Isoprenaline stimulation caused insignificant decreases in ΔTPeak, max and Tpeak SD/CC in control mice. In contrast, isoprenaline significantly increased the dyssynchrony in 4- and 5-month mdx mice though not at a specific region (Supplementary Table 1–3), which has not been reported previously. It has been reported that β-adrenergic stimulation can cause cardiac dyssynchrony if different portions of the myocardium have different sensitivities to β-adrenergic agonists [47]. This could also be the cause of increased dyssynchrony induced by isoprenaline in mdx mice but needs to be further studied.
Significance of this study
Our study shows that catecholamine stress combined with high frequency ultrasound 2D STE is a sensitive noninvasive approach to detect early cardiac dysfunction in mdx mice as young as 3-month old. The reduced response of strains and induced regional contraction dyssynchrony by β-adrenergic stimulation may account for reduced exercise capability of young DMD patients other than degenerated skeletal muscles. So far this is the most sensitive method for studying cardiac abnormalities in this DMD mouse model. It has the potential to diagnose early cardiac dysfunction in very young (e.g., several years old or early teens) DMD patients and help decide when to start the treatment for cardiac dysfunction. This approach is instrumental for evaluating responses to treatment or the effect of different genetic variations in DMD patients and muscular dystrophy animal models. It can also be used to tackle other issues that might be difficult to study in patients with muscular dystrophy.
Limitations
Though our study suggests that the combination of echocardiography and catecholamine or exercise stress test could be a novel way to detect early cardiac dysfunction in young DMD patients, this type of test can only be done in those patients capable of exercise or tolerant of catecholamine/dobutamine stress. Furthermore, our study was performed with a DMD animal model (mdx mouse model) that does not have exactly the same disease process as DMD human patients [21]. Thus, our study needs to be verified with human patients. For example, in human patients, high doses of dobutamine may slightly decrease PSS while low doses of dobutamine may increase PSS. Therefore, we may need to use low dose of dobutamine in DMD patients and normal reference values need to be established in healthy age-matched volunteers. As our study was done under anesthesia causing the reduction of heart rate and cardiac muscle contractility, the ejection fraction and strain values are lower than those obtained at heart rates closer to physiological conditions [18]. Technically, the scanhead (RMV 707B) frame rate used in the study (up to 160fps) may not be ideal for strain analysis at high heart rates (e.g., after ISO) and the algorithm of strain analysis by Tomtec Image Arena may need to be validated with other software more specifically designed for small animals such as the proprietary software used by VisualSonics. However, when the heart rate was comparable (e.g., 500–550 bpm), the strain values obtained with our approach were comparable to those reported with the Veve 2100 machine [18]. Nonetheless, the low frame rates of Vevo 770 may decrease the absolute PSS values measured. In addition, mdx mice younger than 3 months have not been studied.
Conclusions
Our study suggests that 2D-STE could detect the systolic dysfunction of mdx mouse hearts as early as 5 months of age and at even younger ages (3–4 months) when combined with catecholamine stress. This method is feasible, reproducible and sensitive for detecting LV myocardial dysfunction in young mdx mice. The approach that we have used may allow us to evaluate responses to treatments, the effect of different genetic variations, and early cardiac dysfunction in patients with muscular dystrophy. Further investigation is warranted to confirm the utility of this new, sensitive and quantitative technique for detecting early LV dysfunction, and for assessing novel, safe, and efficacious preventive therapies for DMD patients.
Supplementary Material
Highlights.
Cardiac dysfunction becomes an important contributing factor for mortality and morbidity of muscular dystrophy patients
There is still a lack of reliable approach to diagnose early cardiac dysfunction in DMD patients
The combination of 2D strain analysis with isoprenaline stress showed reduced β-adrenergic reserve and increased contractile dyssynchrony in mdx mice at a very early stage
2D strain analysis with stress test is a feasible and sensitive approach to diagnose early cardiac function and to evaluate treatments in DMD patients
The treatment of cardiac dysfunction should be started at young age for DMD patients
Acknowledgments
Source of Funding: This study was supported by NIH HL088243, HL088243-03S1and AHA 0730347N to XC and by the Ministry of Health of China grant (No. 201202002 to QL).
Footnotes
Disclosures: None declared
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Judge DP, Kass DA, Thompson WR, Wagner KR. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. Am J Cardiovasc Drugs. 2011;11:287–94. doi: 10.2165/11594070-000000000-00000. [DOI] [PubMed] [Google Scholar]
- 2.Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Assoc Nurse Prac. 2009;21:241–9. doi: 10.1111/j.1745-7599.2009.00404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Politano L, Nigro G. Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol. 2012;31:24–30. [PMC free article] [PubMed] [Google Scholar]
- 4.Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2008;21:1049–54. doi: 10.1016/j.echo.2008.03.001. [DOI] [PubMed] [Google Scholar]
- 5.Spurney CF, McCaffrey FM, Cnaan A, Morgenroth LP, Ghelani SJ, Gordish-Dressman H, et al. Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies. J Am Soc Echocardiogr. 2015;28:999–1008. doi: 10.1016/j.echo.2015.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Willmann R, Possekel S, Dubach-Powell J, Meier T, Ruegg MA. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord. 2009;19:241–9. doi: 10.1016/j.nmd.2008.11.015. [DOI] [PubMed] [Google Scholar]
- 7.Partridge TA. The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J. 2013;280:4177–86. doi: 10.1111/febs.12267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhou YQ, Foster FS, Nieman BJ, Davidson L, Chen XJ, Henkelman RM. Comprehensive transthoracic cardiac imaging in mice using ultrasound biomicroscopy with anatomical confirmation by magnetic resonance imaging. Physiol Genomics. 2004;18:232–44. doi: 10.1152/physiolgenomics.00026.2004. [DOI] [PubMed] [Google Scholar]
- 9.Li Y, Garson CD, Xu Y, Beyers RJ, Epstein FH, French BA, et al. Quantification and MRI validation of regional contractile dysfunction in mice post myocardial infarction using high resolution ultrasound. Ultrasound Med Biol. 2007;33:894–904. doi: 10.1016/j.ultrasmedbio.2006.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Li Y, Garson CD, Xu Y, French BA, Hossack JA. High frequency ultrasound imaging detects cardiac dyssynchrony in noninfarcted regions of the murine left ventricle late after reperfused myocardial infarction. Ultrasound Med Biol. 2008;34:1063–75. doi: 10.1016/j.ultrasmedbio.2007.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Spurney C, Yu Q, Nagaraju K. Speckle tracking analysis of the left ventricular anterior wall shows significantly decreased relative radial strain patterns in dystrophin deficient mice after 9 months of age. PLoS Curr. 2011;3:RRN1273. doi: 10.1371/currents.RRN1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995;77:632–7. doi: 10.1161/01.res.77.3.632. [DOI] [PubMed] [Google Scholar]
- 13.Turner MJ, Mier CM, Spina RJ, Schechtman KB, Ehsani AA. Effects of age and gender on the cardiovascular responses to isoprenaline. J Gerontol A Biol Sci Med Sci. 1999;54:B393–400. doi: 10.1093/gerona/54.9.b393. [DOI] [PubMed] [Google Scholar]
- 14.Li Y, Zhang S, Zhang X, Li J, Ai X, Zhang L, et al. Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy. Cardiovasc Res. 2014;103:60–71. doi: 10.1093/cvr/cvu119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wong BL, Mukkada VA, Markham LW, Cripe LH. Depressed left ventricular contractile reserve diagnosed by dobutamine stress echocardiography in a patient with Duchenne muscular dystrophy. J Child Neurol. 2005;20:246–8. doi: 10.1177/08830738050200031401. [DOI] [PubMed] [Google Scholar]
- 16.Li D, Long C, Yue Y, Duan D. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Human Mol Genet. 2009;18:1209–20. doi: 10.1093/hmg/ddp015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gao S, Ho D, Vatner DE, Vatner SF. Echocardiography in Mice. Curr Protoc Mouse Biol. 2011;1:71–83. doi: 10.1002/9780470942390.mo100130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, Trujillo A, et al. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res. 2011;108:908–16. doi: 10.1161/CIRCRESAHA.110.239574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.A 15-year-old male with progressive muscular dystrophy of the becker type and severe heart failure. Arq Bras Cardiol. 2000;74:360–4. doi: 10.1590/s0066-782x2000000400008. [DOI] [PubMed] [Google Scholar]
- 20.Ogata H, Nakatani S, Ishikawa Y, Negishi A, Kobayashi M, Ishikawa Y, et al. Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy. Int J Cardiol. 2007;115:190–5. doi: 10.1016/j.ijcard.2006.02.013. [DOI] [PubMed] [Google Scholar]
- 21.Banks GB, Chamberlain JS. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Current Top Dev Biol. 2008;84:431–53. doi: 10.1016/S0070-2153(08)00609-1. [DOI] [PubMed] [Google Scholar]
- 22.Mazur W, Nagueh SF. Stress echocardiography in the diagnosis of coronary artery disease. Curr Atheroscler Rep. 2001;3:109–16. doi: 10.1007/s11883-001-0046-3. [DOI] [PubMed] [Google Scholar]
- 23.D’Hooge J, Heimdal A, Jamal F, Kukulski T, Bijnens B, Rademakers F, et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr. 2000;1:154–70. doi: 10.1053/euje.2000.0031. [DOI] [PubMed] [Google Scholar]
- 24.Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol. 2005;26:66–72. doi: 10.1007/s00246-004-0689-2. [DOI] [PubMed] [Google Scholar]
- 25.Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR, Hoffman EP. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord. 2008;18:371–81. doi: 10.1016/j.nmd.2008.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Li Z, Li Y, Zhang X, Ai X, Zhang L, Szeto C, et al. The Heart in Duchenne Muscular Dystrophy Mouse Model (mdx Mice) Loses Beta-Adrenergic Reserve at Early Age Before the Onset of Heart Failure (abstract) Circulation. 2011;124:A18335. [Google Scholar]
- 27.Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord. 2004;14:491–6. doi: 10.1016/j.nmd.2004.04.007. [DOI] [PubMed] [Google Scholar]
- 28.Mori K, Hayabuchi Y, Inoue M, Suzuki M, Sakata M, Nakagawa R, et al. Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne’s progressive muscular dystrophy. Echocardiography. 2007;24:598–608. doi: 10.1111/j.1540-8175.2007.00437.x. [DOI] [PubMed] [Google Scholar]
- 29.Ryan TD, Taylor MD, Mazur W, Cripe LH, Pratt J, King EC, et al. Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients. Pediatr Cardiol. 2013;34:1159–65. doi: 10.1007/s00246-012-0622-z. [DOI] [PubMed] [Google Scholar]
- 30.Armstrong WF, Ryan T. Stress echocardiography from 1979 to present. J Am Soc Echocardiogr. 2008;21:22–8. doi: 10.1016/j.echo.2007.11.005. [DOI] [PubMed] [Google Scholar]
- 31.Aragona P, Galati A, Savino K, Pino GP, Terranova A. Stress echocardiography in valvular heart disease. G Ital Cardiol. 2007;8:735–48. [PubMed] [Google Scholar]
- 32.Scherrer-Crosbie M, Thibault HB. Echocardiography in translational research: of mice and men. J Am Soc Echocardiogr. 2008;21:1083–92. doi: 10.1016/j.echo.2008.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109–17. doi: 10.1161/01.cir.94.5.1109. [DOI] [PubMed] [Google Scholar]
- 34.Daniels A, van Bilsen M, Janssen BJ, Brouns AE, Cleutjens JP, Roemen TH, et al. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling. Acta Physiol (Oxf) 2010;200:11–22. doi: 10.1111/j.1748-1716.2010.02102.x. [DOI] [PubMed] [Google Scholar]
- 35.Wang J, Chen W, Ruan L, Toprak A, Srinivasan SR, Berenson GS. Differential effect of elevated blood pressure on left ventricular geometry types in black and white young adults in a community (from the Bogalusa Heart Study) Am J Cardiol. 2011;107:717–22. doi: 10.1016/j.amjcard.2010.10.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH. Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. JACC Cardiovasc Imaging. 2010;3:121–31. doi: 10.1016/j.jcmg.2009.09.025. [DOI] [PubMed] [Google Scholar]
- 37.Cheng A, Nguyen TC, Malinowski M, Daughters GT, Miller DC, Ingels NB., Jr Heterogeneity of left ventricular wall thickening mechanisms. Circulation. 2008;118:713–21. doi: 10.1161/CIRCULATIONAHA.107.744623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zhong J, Liu W, Yu X. Characterization of three-dimensional myocardial deformation in the mouse heart: an MR tagging study. J Magn Reson Imaging. 2008;27:1263–70. doi: 10.1002/jmri.21367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Becker M, Ocklenburg C, Altiok E, Futing A, Balzer J, Krombach G, et al. Impact of infarct transmurality on layer-specific impairment of myocardial function: a myocardial deformation imaging study. Eur Heart J. 2009;30:1467–76. doi: 10.1093/eurheartj/ehp112. [DOI] [PubMed] [Google Scholar]
- 40.Schuster A, Kutty S, Padiyath A, Parish V, Gribben P, Danford DA, et al. Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. J Cardiovasc Magn Reson. 2011;13:58. doi: 10.1186/1532-429X-13-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Armour JA. Cardiac neuronal hierarchy in health and disease. Am J Physiol Regul Integr Comp Physiol. 2004;287:R262–71. doi: 10.1152/ajpregu.00183.2004. [DOI] [PubMed] [Google Scholar]
- 42.Shirokova N, Niggli E. Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. J Mol Cell Cardiol. 2013;58:217–24. doi: 10.1016/j.yjmcc.2012.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Thomas TO, Morgan TM, Burnette WB, Markham LW. Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy. Pediatr Cardiol. 2012;33:1175–9. doi: 10.1007/s00246-012-0281-0. [DOI] [PubMed] [Google Scholar]
- 44.Hees PS, Fleg JL, Mirza ZA, Ahmed S, Siu CO, Shapiro EP. Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol. 2006;47:1440–7. doi: 10.1016/j.jacc.2005.11.052. [DOI] [PubMed] [Google Scholar]
- 45.Kirk JA, Kass DA. Electromechanical dyssynchrony and resynchronization of the failing heart. Circ Res. 2013;113:765–76. doi: 10.1161/CIRCRESAHA.113.300270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Li W, Liu W, Zhong J, Yu X. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging. J Cardiovasc Magn Reson. 2009;11:40. doi: 10.1186/1532-429X-11-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Gwirtz PA, Franklin D, Mass HJ. Modulation of synchrony of left ventricular contraction by regional adrenergic stimulation in conscious dogs. Am J Physiol. 1986;251:H490–5. doi: 10.1152/ajpheart.1986.251.3.H490. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







